Activation of NF-κB in NSCLC is frequently mediated by the PI3K/AKT pathway, which is triggered by growth factors, cytokines, or mutations in key oncogenes, such as KRAS and EGFR [61]. Here, NFKB1 is linked to non-small cell lung carcinoma.